Status:

UNKNOWN

Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-craniotomy Pain

Lead Sponsor:

Beijing Tiantan Hospital

Conditions:

Pain, Postoperative

Eligibility:

All Genders

18-64 years

Phase:

PHASE4

Brief Summary

According to recent studies, patients following craniotomy suffer more than minimal pain; two-thirds of patients experienced moderate to severe pain. Postoperative pain most often occurs within 48 hou...

Eligibility Criteria

Inclusion

  • Patients scheduled for elective craniotomy under general anesthesia;
  • Age 18-64 years;
  • American Society of Anesthesiologists (ASA) physical status of I or II;
  • Anticipated tracheal extubation, full recovery and cooperation within 2 hours postoperatively
  • Patients required to fix their head in a head clamp during the operation.

Exclusion

  • Previous history of craniotomy;
  • Plan to delay extubation or no plan to extubate;
  • Patients who cannot use the patient-controlled analgesia (PCA) device;
  • Patients who cannot comprehend the instructions of a numeric rating scale (NRS) before craniotomy;
  • Body mass index (BMI) \<15 or \>35;
  • Allergy to dexamethasone, lipid microsphere, opioids or ropivacaine;
  • History of drug abuse or excessive alcohol, chronic opioids use (more than 2 weeks), or use of any sedative or analgesic before surgery;
  • History of uncontrolled epilepsy, psychiatric disorders or chronic headache;
  • Pregnant or at breastfeeding;
  • Symptomatic cardiopulmonary, liver or renal dysfunction or combined with diabetes or other systemic dysfunction;
  • Glasgow Coma Scale \<15 before the surgery;
  • Intracranial hypertension;
  • Peri-incisional infection;
  • Patients who have received chemoradiotherapy before the surgery or expected to receive postoperative chemoradiotherapy according to the preoperative imaging.

Key Trial Info

Start Date :

October 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 25 2023

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT04488315

Start Date

October 1 2022

End Date

December 25 2023

Last Update

November 21 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100070